Latest stories on NUVB
Nuvation Bio Inc. (NUVB) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
Seeking Alpha56 · neutralgeneral
Lightning Round: I would own GE Vernova over Nuscale, says Jim Cramer
CNBC56 · neutralanalyst
Cramer's lightning round: Nuvation Bio 'is a pure spec'
CNBC42 · neutralanalyst
Nuvation Bio to Participate in Upcoming Investor Conferences
PR Newswire56 · neutralgeneral
Nuvation: Why I'm Downgrading To Hold Despite Progress On NSCLC And Glioma Fronts
Seeking Alpha46 · neutralanalyst
Why is Nuvation Bio stock rallying today?
Investing.com Markets50 · neutralgeneral
Nuvation Bio stock rises after Cantor starts at Overweight
Investing.com Markets63 · neutralanalyst
Nuvation Bio rises as Cantor initiates at overweight
Seeking Alpha63 · neutralanalyst
Cantor Fitzgerald initiates Nuvation Bio stock with overweight rating
Investing.com Analyst Ratings61 · neutralanalyst
Nuvation Bio initiated with an Overweight at Cantor Fitzgerald
The Fly61 · neutralanalyst
FDA Fast Track Designation for Safusidenib Highlights Nuvation Bio’s Breakthrough in IDH1-Mutant Glioma
August 20, 2026
MarketChameleon73 · bullishproduct/pr
Nuvation granted Fast Track status for safusidenib for brain tumors
Seeking Alpha73 · bullishproduct/pr
Nuvation Bio Granted FDA Fast-Track Designation for Glioma Treatment
MarketWatch63 · neutralproduct/pr
Nuvation Bio granted FDA Fast Track Designation for safusidenib in glioma
The Fly63 · neutralproduct/pr
Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
StockTitan71 · bullishproduct/pr
Nuvation wins new Overweight at J.P. Morgan on launch trajectory for lead drug
Seeking Alpha67 · bullishanalyst
Nuvation Bio initiated with an Overweight at JPMorgan
The Fly63 · neutralanalyst
JPMorgan initiates Nuvation Bio stock coverage with overweight rating
Investing.com Analyst Ratings61 · neutralanalyst
Nuvation Bio (NUVB) Q2 2026 Earnings Call Transcript
The Motley Fool59 · neutralearnings
Nuvation Bio Q2 Earnings Call Highlights
Yahoo Top56 · neutralearnings
Nuvation Bio Price Target Raised To 20 From 19 At Rbc Capital
The Fly63 · neutralanalyst
Nuvation Bio outlines $30M Eisai milestone timing while expanding safusidenib studies with PFS readouts expected in 2029
Seeking Alpha59 · neutralgeneral
Nuvation Bio Inc. (NUVB) Q2 2026 Earnings Call Transcript
Seeking Alpha56 · neutralearnings
Nuvation Bio Inc. (NUVB) files 8-K
SEC 8-K50 · neutralgeneral
Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
PR Newswire56 · neutralearnings